Chinyu Su Selected Research

Clostridium Infections

7/2022

Clostridium difficile Infection in Patients with Ulcerative Colitis Treated with Tofacitinib in the Ulcerative Colitis Program.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chinyu Su Research Topics

Disease

41	Ulcerative Colitis 07/2022 - 10/2002
7	Herpes Zoster 06/2022 - 01/2017
6	Infections 06/2022 - 01/2017
6	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2021 - 10/2002
6	Rheumatoid Arthritis 01/2021 - 01/2018
5	Skin Neoplasms (Skin Cancer) 01/2022 - 01/2017
5	Crohn Disease (Crohn's Disease) 01/2019 - 10/2002
4	Necrosis 12/2021 - 01/2005
4	Neoplasms (Cancer) 01/2021 - 01/2019
4	Psoriatic Arthritis 01/2021 - 01/2018
3	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2021 - 11/2018
2	Pulmonary Embolism 01/2021 - 11/2019
2	Venous Thrombosis (Deep-Vein Thrombosis) 01/2021 - 11/2019
2	Inflammation (Inflammations) 01/2021 - 01/2020
2	Opportunistic Infections (Opportunistic Infection) 01/2021 - 01/2019
2	Opioid-Induced Constipation 11/2011 - 11/2009
1	Clostridium Infections 07/2022
1	Atherosclerosis 01/2021
1	Body Weight (Weight, Body) 01/2021
1	Hyperlipidemias (Hyperlipidemia) 01/2021
1	Venous Thromboembolism 11/2019
1	Melanoma (Melanoma, Malignant) 01/2019
1	Hemorrhage 01/2019
1	Fetal Death 11/2018
1	Muscle Cramp (Cramp) 11/2011
1	Abdominal Pain (Pain, Abdominal) 11/2011
1	Constipation 11/2009
1	Substance Withdrawal Syndrome (Withdrawal Symptoms) 11/2009
1	Pain (Aches) 11/2009
1	Metabolic Bone Diseases (Osteopenia) 04/2006
1	Osteoporosis 04/2006

Drug/Important Bio-Agent (IBA)

37	tofacitinibIBA 07/2022 - 08/2012
28	Janus Kinase InhibitorsIBA 07/2022 - 08/2012
5	Tumor Necrosis Factor InhibitorsIBA 06/2022 - 01/2017
4	Infliximab (Remicade)FDA Link 01/2017 - 10/2002
3	LipidsIBA 01/2021 - 01/2017
2	C-Reactive ProteinIBA 04/2022 - 12/2021
2	Pharmaceutical PreparationsIBA 01/2022 - 09/2019
2	Creatine Kinase (Creatine Phosphokinase)IBA 09/2021 - 01/2021
2	Biological ProductsIBA 01/2021 - 01/2019
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2019 - 04/2006
2	methylnaltrexone FDA Link 11/2011 - 11/2009
2	CytokinesIBA 04/2006 - 10/2002
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2006 - 10/2002
1	Delayed-Action PreparationsIBA 01/2022
1	P-2 (P 2)IBA 06/2021
1	omega-Chloroacetophenone (Mace)IBA 01/2021
1	lipoprotein cholesterolIBA 01/2021
1	CreatinineIBA 01/2021
1	AlbuminsIBA 01/2021
1	CholesterolIBA 01/2021
1	Immunosuppressive Agents (Immunosuppressants)IBA 09/2019
1	Janus KinasesIBA 01/2018
1	Adalimumab (Humira)FDA Link 01/2017
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 01/2016
1	mu Opioid Receptors (mu Opioid Receptor)IBA 11/2009
1	Opioid Analgesics (Opioids)IBA 11/2009
1	LaxativesIBA 11/2009
1	Diphosphonates (Bisphosphonates)IBA 04/2006
1	Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric 06/2004
1	Azathioprine (Imuran)FDA LinkGeneric 06/2004
1	Monoclonal AntibodiesIBA 10/2002

Therapy/Procedure

14	Therapeutics 04/2022 - 10/2002
1	Aftercare (After-Treatment) 11/2021
1	Drug Tapering 07/2021
1	Analgesia 11/2009